An examination of payer coverage for multiple sclerosis drugs shows variation in how these drugs are covered and in the evidence that payers review to make these decisions.
Jordan E. Anderson, BA
Advertisement
Articles by Jordan E. Anderson, BA
Advertisement
Latest Updated Articles
- Variation in the Coverage of Disease-Modifying Multiple Sclerosis Drugs Among US Payers
Published: September 21st 2017 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Reformulated Ranitidine After 5-Year Absence
2
Zuranolone Offers New Hope for Postpartum Depression
3
Redefining the Role of GLP-1 Therapies: The Clinical Trials Behind the Expanding Indications
4
Updated Hypertension Guidelines Are Here
5
